Indian Pharma Soars with Record US Generic Drug Profits
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
Category : Search result: pharma fundraising
AstraZeneca Q3 Profit Jumps 77% to $2.53 Billion
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma Bets on US Biopharma Funding Revival
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Man funds wedding selling suit ads, raises ₹8.86 lakh
A resourceful Indian man turned down big corporate deals and instead sold advertising space on his wedding suit, raising an impressive ₹8.86 lakh through small businesses and individual sponsors.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
₹250 Cr Fundraising Approved: Sub-₹100 Stock in Spotlight
A prominent company's board has approved raising ₹250 crore through various instruments, putting this affordable stock under ₹100 in the spotlight for investors seeking high-growth opportunities.
Adani Energy Solutions Board Meets for Fundraising
Adani Energy Solutions board to meet Thursday to consider fundraising options, potentially impacting share price. Key details investors need to know.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Adani Enterprises to raise ₹25,000 crore via rights issue
Adani Enterprises board greenlights massive ₹25,000 crore fundraising through rights issue, signaling strong growth ambitions and market confidence in the conglomerate's expansion plans.
Penny Stock Under ₹2 Sets Board Meeting for Q2 Results
Discover how this sub-₹2 penny stock is gearing up for its Q2 FY2025 results announcement and revised fundraising strategy in an upcoming board meeting that could impact investors.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Vodafone Idea Shares Surge 10% in Market Rally
Vodafone Idea's stock witnessed a massive 10% surge as fundraising hopes and positive market sentiment ignited investor interest. Discover the key factors behind this telecom stock's impressive performance.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Swifties Unite to Fight Hunger Amid SNAP Benefit Cuts
Taylor Swift's dedicated fanbase, the Swifties, are mobilizing to combat food insecurity as millions of Americans risk losing crucial food stamp benefits. Discover how this powerful fandom is turning concert excitement into humanitarian action.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
3i Infotech Rights Issue Oversubscribed 1.47x
3i Infotech's rights issue receives overwhelming investor response, oversubscribing by 1.47 times and successfully raising ₹64.10 crore to fuel growth initiatives.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Small-Cap Stock Under ₹500 Defers Rights Issue
Discover why a promising small-cap stock under ₹500 has strategically deferred its rights issue funding plan. Get exclusive insights into market timing and corporate strategy.
LIC Housing Finance to Raise Funds via NCDs
LIC Housing Finance announces board meeting to consider fundraising through Non-Convertible Debentures. Get exclusive insights into the strategic move and market implications.
IPO Boom: 6 Firms Target ₹1800 Cr Fundraise
Six Indian companies including Lenskart and Orkla India are gearing up for massive IPOs, aiming to raise over ₹1800 crore in what could be a game-changing moment for Indian markets.
Mukul Agrawal's ₹200 Cr Pharma Stock Bet Revealed
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Elon Musk Missing From Trump's White House Donor List
In a surprising revelation, Elon Musk's name is conspicuously absent from Donald Trump's list of major donors for White House events. Discover who made the cut and why the Tesla billionaire didn't contribute.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Q2: Profit Halves, Revenue Down 19%
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Page 1 of 2